Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × Immunotherapy, Adoptive × Clear all

NCT04512716 2026-02-17

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

NCT05800405 2026-02-04

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT05587543 2024-11-12

Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma

Phase EARLY_PHASE1 Recruiting

Nasopharyngeal Carcinoma

NCT06642025 2024-10-15

EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04532203 2020-10-26

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma